About this trial
This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.
Eligibility criteria
Qualifiers
Diagnosis of an acute spontaneous ICH based on non-contrast CT
Time from symptom onset to anticipated start of cerebral DSA of under 3 hours
Agreement of the treating physician to perform DSA
Informed consent documented by signature or fulfilling the criteria for emergency consent procedures (deferral of consent)
Disqualifiers
High probability that the etiology of the bleeding is a ruptured aneurysm, an arteriovenous malformation or an amyloid angiopathy as judged by the treating physician
Any time critical surgical or minimal invasive intervention is planned
Evidence of an ongoing pregnancy, a negative pregnancy test is mandatory in all persons of childbearing potential
Contraindications against the use of iodine contrast media
Trial design
Treatments tested in this trial
- Diagnostic, cerebral Digital Subtraction Angiography (DSA)
Treatment groups
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
Clinical Trial Unit, University Hospital Basel, Switzerland
Collaborator